申请人:STEALTH BIOTHERAPEUTICS CORP
公开号:WO2020131282A1
公开(公告)日:2020-06-25
Disclosed are analogs of SBT-20. The compounds are useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.